Ribociclib approved as the first-line agent for metastatic breast cancer
Breast cancer is the second leading cause of cancer-related mortality in women, after lung cancer.1 The American Cancer Society...
Oncology
Lynparza as maintenance therapy for BRCA-mutated ovarian cancer patients
Ovarian cancer is the 7th most commonly diagnosed cancer in women worldwide1 and the 5th most common cause of...
US FDA Approves Midostaurin for Treatment of Acute Myeloid Leukemia
The US FDA approved the use of Rydapt (midostaurin) in combination with chemotherapy for treating recently diagnosed adults with...